The Fatigue Severity Scale (FSS) is a 9-item self-report questionnaire that measures the severity of fatigue and its impact on daily functioning, originally developed by Lauren B. Krupp, Nicholas G. LaRocca, Judith Muir-Nash, and Arthur D. Steinberg in 1989 for use with patients with multiple sclerosis (MS) and systemic lupus erythematosus (SLE). Each item is rated on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree), yielding a total score range of 9 to 63. The FSS mean score is calculated by dividing the sum of all 9 items by 9. A mean score of ≥4.0 is widely used as the clinical cutoff for significant fatigue. Internal consistency is excellent (Cronbach’s α = 0.94), and test-retest reliability is strong (r = 0.82). Zentake delivers the FSS digitally with automatic mean score calculation and clinical threshold flagging.
To score the FSS, sum all 9 item responses and divide by 9 to obtain the mean score. The total score range is 9–63; the mean score range is 1.00–7.00.
No subscales are scored separately; the FSS yields a single global fatigue severity score. Zentake automatically calculates the mean FSS score upon form submission and flags scores at or above the clinical cutoff of 4.0.
Step 1: Identify appropriate patients. The FSS is validated for adults across a wide range of chronic conditions including MS, SLE, chronic fatigue syndrome (CFS), Parkinson’s disease, post-stroke, fibromyalgia, and mood disorders. It is a self-report scale completed by the patient.
Step 2: Deliver the form digitally or on paper. With Zentake, send the FSS to patients via text or email before their appointment. Patients typically complete all 9 items in under 5 minutes, making it ideal for routine clinical screening.
Step 3: Review the automatically calculated mean score. Zentake computes the FSS mean score instantly upon submission, eliminating manual summation and division. The platform flags scores ≥ 4.0 to alert the clinician to clinically significant fatigue.
Step 4: Interpret within the clinical context. A score ≥ 4.0 should prompt further evaluation of the underlying cause of fatigue, including disease activity, sleep disturbance, depression, anemia, or medication side effects. The FSS is a screening tool and does not diagnose specific fatigue etiologies.
Step 5: Monitor fatigue longitudinally. Readminister the FSS at follow-up visits to track changes in fatigue severity in response to treatment interventions. Zentake’s measures dashboard visualizes FSS score trends over time.
Scoring: Paper requires manual summation of 9 items and division by 9. Zentake computes the mean score instantly and flags clinical thresholds automatically.
Completion: Paper forms are administered in-office. Zentake sends the FSS to patients via text or email for pre-visit completion, reducing in-session paperwork time.
Delivery: Paper is limited to in-person settings. Zentake supports telehealth and remote monitoring for any care model.
Data Storage: Paper responses require manual filing. Zentake stores all FSS results in a HIPAA-compliant cloud environment with full audit capabilities.
Longitudinal Tracking: Paper requires manual comparison across visits. Zentake’s dashboard displays FSS score trends over time automatically.
Security: Paper forms risk physical loss or unauthorized access. Zentake encrypts all data at rest and in transit.
Integration: Paper cannot connect to EMR systems. Zentake exports FSS data directly to supported EMR platforms.
Cost: Paper printing, storage, and manual scoring consume staff time. Zentake’s per-provider pricing eliminates these overhead costs.
What does the FSS measure?
The FSS measures the severity of fatigue and its impact on daily activities. It does not diagnose a specific condition but quantifies how much fatigue interferes with functioning. Zentake delivers the 9-item FSS digitally with automatic mean score calculation and clinical threshold flagging.
How do you score the FSS?
Sum all 9 item responses (each rated 1–7) and divide by 9 to get the mean score. A mean score ≥ 4.0 indicates clinically significant fatigue. Zentake performs this calculation automatically upon form submission.
What is the FSS cutoff score for significant fatigue?
A mean FSS score ≥ 4.0 is the most widely validated cutoff for clinically significant fatigue across multiple conditions including MS, SLE, and CFS. Some studies use ≥ 4.95 to identify chronic fatigue syndrome presentations, and ≥ 5.4 for fatigue associated with major depression.
How long does the FSS take to complete?
Patients typically complete the FSS in under 5 minutes. The brevity of the 9-item scale makes it ideal for routine clinical screening. When delivered through Zentake, patients complete it before their appointment, saving in-session time.
What conditions is the FSS used for?
The FSS was originally validated for multiple sclerosis and systemic lupus erythematosus. It has since been validated for chronic fatigue syndrome, Parkinson’s disease, post-stroke fatigue, fibromyalgia, hepatitis C, mood disorders, and other chronic conditions.
Is the FSS free to use?
The FSS is freely available in the public domain, published in the original Krupp et al. (1989) paper. Zentake provides a ready-to-use digital version with automated scoring. Start a free trial at zentake.com.
Who should administer the FSS?
The FSS is a self-report measure completed by the patient without clinician assistance. Any healthcare provider working with patients experiencing fatigue — including neurologists, rheumatologists, PCPs, psychiatrists, and rehabilitation specialists — can use the FSS as part of routine assessment. Zentake automates delivery and results reporting.
Can the FSS detect changes after treatment?
Yes. The FSS has been shown to be responsive to treatment-related changes in fatigue severity. It is commonly used as an outcome measure in clinical trials and longitudinal patient monitoring. Zentake’s measures dashboard makes it easy to visualize FSS score trends across multiple time points.
1. Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.
2. Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33(2), 123–130.
3. Valko, P. O., Bassetti, C. L., Bloch, K. E., Held, U., & Baumann, C. R. (2008). Validation of the fatigue severity scale in a Swiss cohort. Sleep, 31(11), 1601–1607.
4. Rosti-Otajärvi, E., Hämäläinen, P., Wikström, J., & Ruutiainen, J. (2017). Validity and reliability of the fatigue severity scale in Finnish multiple sclerosis patients. Brain and Behavior, 8(6), e00743.
Last updated: April 2026
The leading patient intake platform. HIPAA compliant forms for healthcare providers and organizations. Find out what you're missing!
